Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Structural and Functional Retinal Alterations in Patients Under Treatment With BRAF/MEK Inhibitors

NCT07431489 is registered in ClinicalTrials.gov with Institute of Oncology Ljubljana as lead sponsor.

NCT NCT07431489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07431489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Structural and Functional Retinal Alterations in Patients Under Treatment With BRAF/MEK Inhibitors
Lead sponsor
Institute of Oncology Ljubljana
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2023
Completion date
January 31, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma, mek inhibitor-associated retinopathy